DE60018785D1 - Immunoassay von c-peptid-enthaltenden verunreinigungen in rekombinantem human-insulin - Google Patents

Immunoassay von c-peptid-enthaltenden verunreinigungen in rekombinantem human-insulin

Info

Publication number
DE60018785D1
DE60018785D1 DE60018785T DE60018785T DE60018785D1 DE 60018785 D1 DE60018785 D1 DE 60018785D1 DE 60018785 T DE60018785 T DE 60018785T DE 60018785 T DE60018785 T DE 60018785T DE 60018785 D1 DE60018785 D1 DE 60018785D1
Authority
DE
Germany
Prior art keywords
peptide
human insulin
immunoassay
recombinant human
containing contaminants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60018785T
Other languages
English (en)
Other versions
DE60018785T2 (de
Inventor
Martin Gerl
Cornelia Steinert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Priority to DE60018785T priority Critical patent/DE60018785T2/de
Application granted granted Critical
Publication of DE60018785D1 publication Critical patent/DE60018785D1/de
Publication of DE60018785T2 publication Critical patent/DE60018785T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/62Insulins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831Protein or peptide standard or control [e.g., hemoglobin, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE60018785T 1999-10-27 2000-10-25 Immunoassay von c-peptid-enthaltenden verunreinigungen in rekombinantem human-insulin Expired - Lifetime DE60018785T2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE60018785T DE60018785T2 (de) 1999-10-27 2000-10-25 Immunoassay von c-peptid-enthaltenden verunreinigungen in rekombinantem human-insulin

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19951684 1999-10-27
DE19951684A DE19951684A1 (de) 1999-10-27 1999-10-27 Neuer immunologischer Assay zur Bestimmung von C-peptidhaltigen Kontaminanten in Proben von Humanisulin und dessen Derivaten
DE60018785T DE60018785T2 (de) 1999-10-27 2000-10-25 Immunoassay von c-peptid-enthaltenden verunreinigungen in rekombinantem human-insulin
PCT/EP2000/010482 WO2001031336A2 (en) 1999-10-27 2000-10-25 Immunoassay of c-peptide containing impurities in human insulin

Publications (2)

Publication Number Publication Date
DE60018785D1 true DE60018785D1 (de) 2005-04-21
DE60018785T2 DE60018785T2 (de) 2006-02-02

Family

ID=7927008

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19951684A Withdrawn DE19951684A1 (de) 1999-10-27 1999-10-27 Neuer immunologischer Assay zur Bestimmung von C-peptidhaltigen Kontaminanten in Proben von Humanisulin und dessen Derivaten
DE60018785T Expired - Lifetime DE60018785T2 (de) 1999-10-27 2000-10-25 Immunoassay von c-peptid-enthaltenden verunreinigungen in rekombinantem human-insulin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19951684A Withdrawn DE19951684A1 (de) 1999-10-27 1999-10-27 Neuer immunologischer Assay zur Bestimmung von C-peptidhaltigen Kontaminanten in Proben von Humanisulin und dessen Derivaten

Country Status (9)

Country Link
US (1) US7169562B1 (de)
EP (1) EP1228374B1 (de)
JP (1) JP4601884B2 (de)
AT (1) ATE291232T1 (de)
AU (1) AU1275301A (de)
DE (2) DE19951684A1 (de)
ES (1) ES2238323T3 (de)
PT (1) PT1228374E (de)
WO (1) WO2001031336A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11524987B2 (en) 2018-09-25 2022-12-13 Amphastar Pharmaceuticals, Inc. Highly purified recombinant human insulin (RHI) API and methods of producing the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744327A (en) * 1990-02-20 1998-04-28 Board Of Regents, The University Of Texas System Methods for producing insulin in response to non-glucose secretagogues
JP3044569B2 (ja) * 1990-11-09 2000-05-22 東ソー株式会社 ヒトc―ペプチドの測定方法
GB9307491D0 (en) * 1993-04-08 1993-06-02 Sandoz Ltd Organic compounds
FR2764989B1 (fr) * 1997-06-20 1999-08-27 Pasteur Sanofi Diagnostics Procede de dosage du c-peptide
US6444641B1 (en) * 1997-10-24 2002-09-03 Eli Lilly Company Fatty acid-acylated insulin analogs

Also Published As

Publication number Publication date
WO2001031336A3 (en) 2001-11-08
PT1228374E (pt) 2005-07-29
ATE291232T1 (de) 2005-04-15
DE19951684A1 (de) 2001-05-03
ES2238323T3 (es) 2005-09-01
WO2001031336A2 (en) 2001-05-03
DE60018785T2 (de) 2006-02-02
JP4601884B2 (ja) 2010-12-22
JP2003513243A (ja) 2003-04-08
US7169562B1 (en) 2007-01-30
AU1275301A (en) 2001-05-08
EP1228374A2 (de) 2002-08-07
EP1228374B1 (de) 2005-03-16

Similar Documents

Publication Publication Date Title
ATE128237T1 (de) Test für hepatitis-c.
BR9809443A (pt) Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão.
BR9712298A (pt) Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão
DE59009163D1 (de) Diagnostischer Nachweis unter Verwendung von chimären Antikörpern.
DE69230917D1 (de) Verfahren zur detektion von hepatitis c
DK0457804T3 (da) M-CSF-monoklonale antistoffer, som genkender en neutraliserende, konformational epitop
Ji et al. Composition and peptide maps of cross-linked human choriogonadotropin-receptor complexes on porcine granulosa cells.
ES8503855A1 (es) Procedimiento de inmunoanalisis homogeneo para determinar un analito en una muestra de ensayo.
ATE331732T1 (de) Schaumproteine, monoklonale antikörper dagegen, und deren verwendungen
DE60018785D1 (de) Immunoassay von c-peptid-enthaltenden verunreinigungen in rekombinantem human-insulin
FI913714A0 (fi) Peptider med foer a 1-mikroglobulin karakteristiska antigeniska determinanter.
ATE143673T1 (de) Testverfahren von glykosylierten proteinen unter verwendung eines antikörpers gerichtet gegen reduzierte glykosylierte n-terminal-aminosäuren
DE69833218D1 (de) Verfahren und kit zum nachweis von cryptosporidium oozysten
KR890702030A (ko) 인간 폐표면 활성 물질의 측정 방법
ES2134781T3 (es) Polipeptidos con actividad de receptor dopaminergico humano, acidos nucleicos que codifican dichos polipeptidos y uso de dichos polipeptidos para el cribado de sustancias activas para dichos polipeptidos.
ATA204393A (de) Aufbereitung von lipoproteinhältigen proben
KR890009417A (ko) 모노크로날 항체의 제조방법 및 그것의 이용방법
DE3764142D1 (de) Reagens und methode zur bestimmung von c3a mit immunochemischer analyse.
MXPA02010725A (es) Ensayo serologico para neospora caninum.
KR910001378A (ko) HIV p24 정량 패널
KR880013012A (ko) 항-프리-s- 항체의 분석법
KR860002573A (ko) 펩타이드 항체의 제조방법

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, 65929 FRANKFURT,

8364 No opposition during term of opposition